etoposide has been researched along with Common Bile Duct Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hazama, K; Katoh, H; Kondoh, S; Suzuki, Y; Takahashi, M; Takahashi, Y; Takano, S; Yoshioka, T | 1 |
Kawada, S; Kondo, H; Ootani, I; Sato, T; Shibata, T; Suzuki, H | 1 |
2 other study(ies) available for etoposide and Common Bile Duct Neoplasms
Article | Year |
---|---|
Primary small cell carcinoma of the common bile duct, in which surgical treatment was performed after neoadjuvant chemotherapy: report of a case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Common Bile Duct Neoplasms; Etoposide; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Pancreaticoduodenectomy; Risk Assessment; Treatment Outcome | 2003 |
[Two cases of obstructive jaundice due to extrahepatic carcinoma of the bile duct with marked response to daily oral administration of etoposide].
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cholestasis, Extrahepatic; Common Bile Duct Neoplasms; Etoposide; Female; Floxuridine; Humans; Male; Middle Aged; Picibanil; Remission Induction; Tegafur; Uracil | 1990 |